Document is current
Any future updates will be listed below
-
Authors
Young, Eric D.
Manley, Sharon J.
Beadnell, Thomas C.
Shearin, Alexander E.
Sasaki, Ken
Zimmerman, Rosalyn
Kauffman, Evan
Vivian, Carolyn J.
Parasuram, Aishwarya
Iwakuma, Tomoo
Grandgenett, Paul M.
Hollingsworth, Michael A.
O’Neil, Maura
Welch, Danny R. https://orcid.org/0000-0002-1951-4947
- License Information
-
More Information
Article History
Received: 4 March 2020
Revised: 14 August 2020
Accepted: 3 September 2020
First Online: 7 October 2020
Ethics approval and consent to participate
: All animal studies were approved by the Institutional Animal Care and Use Committee at the University of Kansas Medical Center (IACUC #2017-2409). Any studies using tissue solely obtained from the Rapid Autopsy Program for Pancreas (IRB#091-01) are not considered human subject research because the individuals are not living when the tissue is obtained (per the regulations at 45 CFR 46.102) and therefore would not need IRB approval.
: Not applicable.
: Data supporting the results can be found in Supplemental Fig. . A comprehensive list of antibodies used in this study can be found in Supplemental Table .
: The authors declare no competing interests.
: The authors of this paper have research support from the NIH F30CA216998 (E.D.Y.), Kansas INBRE, P20 GM103418 (S.J.M. and D.R.W.), DOD BCRP BC171381 (T.C.B.), the University of Kansas Cancer Center Summer Student Research Training Program (A.E.S.), the Natl. Fndn. Cancer Res., CA168524, Hall Family Professorship in Molecular Medicine (D.R.W.), SPORE in Pancreatic Cancer, CA127297, TMEN Tumor Microenvironment Network, U54CA163120 and CA36727 (P.M.G. and M.A.H.).
